Menu

Women over 50 lost 35% more weight with this surprising combo
📰

Women over 50 lost 35% more weight with this surprising combo

ScienceDaily·8 months ago
#GadAjg
Reading 0:00
15s threshold

A Mayo Clinic-led study reports that postmenopausal women using menopausal hormone therapy experienced significantly greater weight loss when taking tirzepatide, a Food and Drug Administration-approved medication for overweight and obesity. On average, these women lost about 35% more weight compared to those using tirzepatide alone. The results, published in The Lancet Obstetrics, Gynaecology, & Women's Health , point to new possibilities for treating obesity and related health conditions in women after menopause.

Menopause is often associated with increased weight gain and a higher risk of developing overweight and obesity. These changes can raise the likelihood of serious health problems, including cardiovascular disease and type 2 diabetes. In addition to weight gain, declining estrogen levels during menopause can trigger other changes in the body that may further increase cardiovascular risk.…

Continue reading — create a free account

Join HashtagPLUS to read full articles, follow hashtags, vote, and join the conversation.